Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies
about
Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2The Bioenergetic Health Index: a new concept in mitochondrial translational researchResveratrol decreases fructose-induced oxidative stress, mediated by NADPH oxidase via an AMPK-dependent mechanismAntioxidative diet supplementation reverses high-fat diet-induced increases of cardiovascular risk factors in mice.Association of HMOX1 and NQO1 Polymorphisms with Metabolic Syndrome ComponentsUpdating experimental models of diabetic cardiomyopathyA newly designed curcumin analog Y20 mitigates cardiac injury via anti-inflammatory and anti-oxidant actions in obese rats.Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats.Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice.Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.Resveratrol Inhibition of Rac1-Derived Reactive Oxygen Species by AMPK Decreases Blood Pressure in a Fructose-Induced Rat Model of Hypertension.Mitochondrial Reactive Oxygen Species Mediate Cardiac Structural, Functional, and Mitochondrial Consequences of Diet-Induced Metabolic Heart DiseasePotential Protective Effects of Bioactive Constituents from Chinese Propolis against Acute Oxidative Stress Induced by Hydrogen Peroxide in Cardiac H9c2 Cells.Sudden cardiac death and obesity.Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease.Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series.Longitudinal relationship between metabolic syndrome and periodontal disease among Japanese adults aged ≥70 years: the Niigata Study.Guidelines for the use of flow cytometry and cell sorting in immunological studies.Folic acid prevents cardiac dysfunction and reduces myocardial fibrosis in a mouse model of high-fat diet-induced obesity.Cardiac-specific down-regulation of carnitine palmitoyltransferase-1b (CPT-1b) prevents cardiac remodeling in obese mice.Role of Dietary Antioxidants in the Preservation of Vascular Function and the Modulation of Health and Disease.Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.Effect of the Aged Garlic Extract on Cardiovascular Function in Metabolic Syndrome Rats.Nutrients and Oxidative Stress: Friend or Foe?Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats.Remodeling of myocardium in rat with chronic dyslipidemia and under conditions of verapamil treatment.Ataxia-Telangiectasia Mutated Kinase Deficiency Impairs Autophagic Response Early During Myocardial Infarction.
P2860
Q28359730-F230F07F-C08A-44A1-A2FD-4E537C5DDA1FQ34368877-16B4BBF9-6026-4768-A50D-24DE3E704D23Q34570751-9874C30B-B4AA-4877-870E-DCF1C05970C7Q35422331-AD9A667E-AF15-46B1-8984-3661949D75D8Q35560789-28B8E98E-CF45-4558-8931-6CC28A046924Q35564129-4A91F68A-14DF-4C54-A0AF-7B8237000A6FQ35580597-B13453E7-54E9-4378-A97C-ADE1E0735E94Q35605790-62B846F9-EE2C-4F01-9977-94A39BD0EA77Q35667039-1BA35972-8910-44FB-9970-5EB6A0826CD5Q35731767-637FCF5F-EB79-4120-85DC-B3BDD59FFC31Q35883067-198A4A3A-97D8-4A79-9EC1-420B9A369C23Q36860450-033B483B-1649-496B-86E0-7897B8212F49Q36877638-4B7DEDD6-C8AB-48E1-B39A-5B1A07F39417Q37699886-AD2457F1-2792-46DB-881A-EAA94392E9C5Q38243742-216FA79F-2074-429F-9063-3BE0BC33DFC9Q38595252-D77A79F6-61B3-41CD-AA00-A1A33D5C7BFAQ39418956-BB914067-3D88-484F-8980-D4780A711CB3Q41595085-2B0BE635-5C0A-4B9F-BA17-C72B9149DBC4Q41918189-E8419B45-EEFF-4C6B-915A-948495216A51Q46265232-E4EF1B04-9BD5-43FA-815A-EB95514AB8AAQ46465910-B27352AE-8D0B-4E95-8021-8FD017CF0F85Q46786956-7797B703-E708-4B39-A7F3-193DEEE79798Q51226497-6A009301-AA37-493B-AE0F-558A1A14DFC5Q51357327-9B882E74-75AC-4C9D-A84B-92E232D87C53Q52324285-E4627F08-5B1F-4F70-9395-C37D3AEAFE14Q52682135-66D74678-DB02-4456-8AE3-5A72D60C3D50Q53003626-2FE57F5D-7877-4BFB-8448-2DF5230BC052Q54116253-77F70DDD-7CD4-4E1D-96D4-2FA4ECBF1CA6
P2860
Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@ast
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@en
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@nl
type
label
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@ast
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@en
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@nl
prefLabel
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@ast
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@en
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@nl
P2860
P3181
P1476
Cardiac dysfunction and oxidat ...... pdate on antioxidant therapies
@en
P2093
P2860
P304
P3181
P356
10.2174/1381612811319270003
P407
P577
2013-01-01T00:00:00Z